Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148174 · ClinicalTrials.gov registry record · NA
Predictors and Intervention for Noncompliance
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
NCT00148174: Completed NA study, sponsored by University of Minnesota.
NCT00148174 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 273 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00148174, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
Study Summary
This is a randomized controlled intervention trial in poorly compliant patients, testing whether improved compliance behavior decreases rates of acute rejection risk and graft loss. Hypothesis: A study of an intensive intervention focused on the least compliant patients and beginning 3 months post-transplant. Effective intervention will reduce the number of acute rejection episodes and thus the occurrence of chronic rejection and graft loss.
Interventions
- BEHAVIORAL Intensive telephone followup
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 1998-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT00148174 record still lists
NCT00148174 is an interventional study that assigns participants to a tested intervention. The registered 273 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 1 intervention - of which Intensive telephone followup is the first listed.
NCT00148174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00148174 about?
NCT00148174 is a clinical study titled "Predictors and Intervention for Noncompliance". This is a randomized controlled intervention trial in poorly compliant patients, testing whether improved compliance behavior decreases rates of acute rejection risk and graft loss. Hypothesis: A study of an intensive intervention focused on the least compliant patients and beginning 3 months post-...
What is the current status of trial NCT00148174?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 1998-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT00148174?
The interventions under investigation include: Intensive telephone followup (BEHAVIORAL).
Who is sponsoring clinical trial NCT00148174?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00148174's enrollment target sits among peer trials
273 386th of 2000 higher than 1,614 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07229430 · 273 participants · NA
Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue
- NCT03808922 · 274 participants · Phase 3
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- NCT04573504 · 274 participants · Phase 4
Antibiotics for Severe Perineal Laceration to Prevent Infection Following Repair
- NCT05289557 · 274 participants · Phase 3
The Efficacy and Safety of Bonjesta® for Nausea and Vomiting of Pregnancy in Pregnant Adolescents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia